What's New on the FDA Drugs Site
May 15, 2015
- FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
- FDA Issues Letters to Doctors Who May Have Purchased Counterfeit or Unapproved Prescription Drugs
- From our perspective: The U.S. drug supply chain and patient safety
- Drug Trials Snapshot: Corlanor
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Orange Book (updated)
- National Drug Code Directory
New and Generic Drug Approvals
May 14, 2015
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
---|---|---|---|---|
Bactroban | mupirocin calcium | Ointment;Nasal | Glaxosmithkline | Labeling Revision |
Escitalopram Oxalate | escitalopram oxalate | Tablet; Oral | Mylan Pharma | Approval |
Famvir | famciclovir | Tablet;Oral | Novartis | Manufacturing Change or Addition |
Gilenya | fingolimod | Capsule;Oral | Novartis | Supplement |
Isovue-128 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Isovue-200 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Isovue-250 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Isovue-300 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Isovue-370 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Isovue-M 200 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Isovue-M 300 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
Lamivudine; Zidovudine | lamivudine; zidovudine | Tablet; Oral Suspension | Mylan Labs | Manufacturing Change or Addition |
Paricalcitol | paricalcitol | Solution;Intravenous | Hospira Inc | Manufacturing Change or Addition |
Rufinamide | rufinamide | Tablet;Oral | Glenmark Generics | Tentative Approval |
Sirturo | bedaquiline fumarate | Tablet;Oral | Janssen Therap | Labeling Revision |
Treximet | naproxen sodium; sumatriptan succinate | Tablet;Oral | Pernix Ireland Ltd | Efficacy Supplement with Clinical Data to Support |
Treximet | naproxen sodium; sumatriptan succinate | Tablet;Oral | Pernix Ireland Ltd | Labeling Revision |
Belum ada tanggapan untuk "CDER New May 18, 2015"
Post a Comment